Contact
Please use this form to send email to PR contact of this press release:
Axovant Provides Clinical Program Update for AXO-AAV-GM1, a Novel Investigational Gene Therapy for GM1 Gangliosidosis
TO:
Please use this form to send email to PR contact of this press release:
Axovant Provides Clinical Program Update for AXO-AAV-GM1, a Novel Investigational Gene Therapy for GM1 Gangliosidosis
TO: